Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386894049> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- W4386894049 endingPage "11" @default.
- W4386894049 startingPage "9" @default.
- W4386894049 abstract "There is no widely accepted definition for Interstitial cystitis (IC)/bladder pain syndrome (BPS) and very few effective diagnostic biomarkers. Chizuko Koseki is combining her deep knowledge of both urology and nucleic acid/oligonucleotides to develop innovative treatments for Hunner-type IC (HIC). Patients with IC/BPS are classified as either HIC, presenting with a specific Hunner lesion, or BPS presenting without Hunner lesion. There is a distinct lack of treatments, with only one approved drug; 50% dimethyl sulfoxide (DMSO) as intravesical instillation therapy, with the drug put directly into the bladder. An important study enabled scientists to surmise that HIC is a distinct inflammatory disorder that is characterised by pancystitis with an increase in plasma cells and frequent expansion of clonal B-cells, and epithelial denudation. Koseki is the CEO of TAGCyx Biotechnologies, a pre-clinical stage drug development company based in Komaba Open Laboratory, The University of Tokyo, Japan focused on developing novel nucleic acid-based drugs for therapeutic applications. The company focuses on: autoimmune disease; women's disease; apheresis; thrombosis; and chronic kidney disease. Oligonucleotides are key to Koseki's work; she is using the advantages and characteristics of single strand DNA oligonucleotides to develop some focused disease areas, such as autoimmune diseases, topical applications and women's diseases. The team has established a technology platform called Xenoligo® that can screen and stabilise drug candidates utilising oligonucleotide drug discovery. The platform can generate highly potent and efficacious single strand DNA aptamers. Interstitial cystitis, IC, bladder pain syndrome, BPS, urology, nucleic acid, oligonucleotides, Hunner-type IC, HIC, TAGCyx Biotechnologies, autoimmune disease, women's disease, apheresis, thrombosis, chronic kidney disease, oligonucleotide drug discovery, DNA aptamers." @default.
- W4386894049 created "2023-09-21" @default.
- W4386894049 creator A5026187919 @default.
- W4386894049 date "2023-09-21" @default.
- W4386894049 modified "2023-10-16" @default.
- W4386894049 title "Anti-IFNg DNA aptamer for Hunner Type Interstitial Cystitis" @default.
- W4386894049 doi "https://doi.org/10.21820/23987073.2023.3.9" @default.
- W4386894049 hasPublicationYear "2023" @default.
- W4386894049 type Work @default.
- W4386894049 citedByCount "0" @default.
- W4386894049 crossrefType "journal-article" @default.
- W4386894049 hasAuthorship W4386894049A5026187919 @default.
- W4386894049 hasConcept C126322002 @default.
- W4386894049 hasConcept C129312508 @default.
- W4386894049 hasConcept C185592680 @default.
- W4386894049 hasConcept C24107716 @default.
- W4386894049 hasConcept C2778508898 @default.
- W4386894049 hasConcept C2779134260 @default.
- W4386894049 hasConcept C2909931192 @default.
- W4386894049 hasConcept C552990157 @default.
- W4386894049 hasConcept C55493867 @default.
- W4386894049 hasConcept C71924100 @default.
- W4386894049 hasConcept C77411442 @default.
- W4386894049 hasConceptScore W4386894049C126322002 @default.
- W4386894049 hasConceptScore W4386894049C129312508 @default.
- W4386894049 hasConceptScore W4386894049C185592680 @default.
- W4386894049 hasConceptScore W4386894049C24107716 @default.
- W4386894049 hasConceptScore W4386894049C2778508898 @default.
- W4386894049 hasConceptScore W4386894049C2779134260 @default.
- W4386894049 hasConceptScore W4386894049C2909931192 @default.
- W4386894049 hasConceptScore W4386894049C552990157 @default.
- W4386894049 hasConceptScore W4386894049C55493867 @default.
- W4386894049 hasConceptScore W4386894049C71924100 @default.
- W4386894049 hasConceptScore W4386894049C77411442 @default.
- W4386894049 hasIssue "3" @default.
- W4386894049 hasLocation W43868940491 @default.
- W4386894049 hasOpenAccess W4386894049 @default.
- W4386894049 hasPrimaryLocation W43868940491 @default.
- W4386894049 hasRelatedWork W2000249690 @default.
- W4386894049 hasRelatedWork W2035474551 @default.
- W4386894049 hasRelatedWork W2039221211 @default.
- W4386894049 hasRelatedWork W2188653002 @default.
- W4386894049 hasRelatedWork W2302676166 @default.
- W4386894049 hasRelatedWork W2519141794 @default.
- W4386894049 hasRelatedWork W2748952813 @default.
- W4386894049 hasRelatedWork W2750226088 @default.
- W4386894049 hasRelatedWork W2883842752 @default.
- W4386894049 hasRelatedWork W2899084033 @default.
- W4386894049 hasVolume "2023" @default.
- W4386894049 isParatext "false" @default.
- W4386894049 isRetracted "false" @default.
- W4386894049 workType "article" @default.